Application 761340

Type
BLA
Sponsor
SAMSUNG BIOEPIS CO LTD

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761340Epysqlieculizumab-aagh351(k) InterchangeableRx2026-08-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EPYSQLIECULIZUMAB-AAGHINJECTION;SOLUTION300 mg/30 mL (10 mg/mL)NoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EPYSQLIECULIZUMAB-AAGHTeva Pharmaceuticals USA, Inc.1fa1aa80-1c59-44d4-9841-b6c52882651b2026-07-06Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA761340

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85780SUPPL 2026-04-30
84832SUPPL 2026-01-26
84769ORIG 2026-01-15
84342ORIG 2025-12-01
84143SUPPL 2025-11-13
83275SUPPL 2025-09-03
82151SUPPL 2025-05-05
82283SUPPL 2025-04-30
82160SUPPL 2025-04-30
81567SUPPL 2025-03-14
81553ORIG 2025-03-13
81126SUPPL 2025-02-07
80913SUPPL 2025-02-04
80912SUPPL 2025-02-04
80242SUPPL 2024-11-19
80231SUPPL 2024-11-18
80230SUPPL 2024-11-18
79133ORIG 2024-07-22
79132ORIG 2024-07-22